Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1995 Nov;147(5):1428–1440.

Liver failure induces a systemic inflammatory response. Prevention by recombinant N-terminal bactericidal/permeability-increasing protein.

M A Boermeester 1, A P Houdijk 1, S Meyer 1, M A Cuesta 1, B J Appelmelk 1, R I Wesdorp 1, C E Hack 1, P A Van Leeuwen 1
PMCID: PMC1869528  PMID: 7485405

Abstract

The observed increased susceptibility of patients with fulminant hepatic failure for local and systemic infections has been hypothesized to be due to a failure for the hepatic clearance function and subsequent leaking of endogenous endotoxins into the systemic circulation. However, experimental evidence for such a systemic inflammation during liver failure due to endogenous endotoxemia is lacking. Therefore, we designed a study to clarify whether circulating endotoxins due to liver failure could lead to the development of systemic inflammations. In a rat model for liver failure induced by a two-thirds partial hepatectomy, we evaluated the course of circulating tumor necrosis factor and interleukin-6, changes in blood chemistry and hemodynamics, and histopathological changes in the lungs. Partially hepatectomized animals, but not sham-operated animals, demonstrated cardiac failure, increased levels of creatinin and urea, metabolic acidosis, high plasma levels of tumor necrosis factor and interleukin-6, and an influx of PMNs in the lungs-together indicating the development of a systemic inflammatory response. Continuous infusion of recombinant N-terminal bactericidal/permeability-increasing protein (rBPI23), a well described endotoxin-neutralizing protein, prevented these inflammatory reactions. Ex vivo experiments with rat plasma samples confirmed the presence of circulating endotoxins in partially hepatectomized rats as opposed to those treated with rBPI23. Thus, our results indicate that the early phase of liver failure induces a systemic inflammatory response triggered by circulating endotoxins, which can be prevented by perioperative infusion of rBPI23.

Full text

PDF
1428

Images in this article

1433Figure 2
on p.1433

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarden L. A., De Groot E. R., Schaap O. L., Lansdorp P. M. Production of hybridoma growth factor by human monocytes. Eur J Immunol. 1987 Oct;17(10):1411–1416. doi: 10.1002/eji.1830171004. [DOI] [PubMed] [Google Scholar]
  2. Alexander H. R., Doherty G. M., Venzon D. J., Merino M. J., Fraker D. L., Norton J. A. Recombinant interleukin-1 receptor antagonist (IL-1ra): effective therapy against gram-negative sepsis in rats. Surgery. 1992 Aug;112(2):188–194. [PubMed] [Google Scholar]
  3. Ammons W. S., Kung A. H. Recombinant amino terminal fragment of bactericidal/permeability-increasing protein prevents hemodynamic responses to endotoxin. Circ Shock. 1993 Nov;41(3):176–184. [PubMed] [Google Scholar]
  4. Andersson R., Foss A. Abdominal sepsis following liver resection in the rat. Hepatogastroenterology. 1991 Dec;38(6):547–549. [PubMed] [Google Scholar]
  5. Baigrie R. J., Lamont P. M., Kwiatkowski D., Dallman M. J., Morris P. J. Systemic cytokine response after major surgery. Br J Surg. 1992 Aug;79(8):757–760. doi: 10.1002/bjs.1800790813. [DOI] [PubMed] [Google Scholar]
  6. Bastiaans J. C., Vleeming W. The effect of compensation of acidosis on survival in endotoxin shock. Adv Shock Res. 1981;6:163–174. [PubMed] [Google Scholar]
  7. Bigatello L. M., Broitman S. A., Fattori L., Di Paoli M., Pontello M., Bevilacqua G., Nespoli A. Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am J Gastroenterol. 1987 Jan;82(1):11–15. [PubMed] [Google Scholar]
  8. Bloom R. J., Simon L. M., Benitz W. E. Endotoxin and pulmonary cell injury. Surg Gynecol Obstet. 1988 Aug;167(2):92–98. [PubMed] [Google Scholar]
  9. Brakenhoff J. P., de Groot E. R., Evers R. F., Pannekoek H., Aarden L. A. Molecular cloning and expression of hybridoma growth factor in Escherichia coli. J Immunol. 1987 Dec 15;139(12):4116–4121. [PubMed] [Google Scholar]
  10. Brigham K. L., Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis. 1986 May;133(5):913–927. [PubMed] [Google Scholar]
  11. Callery M. P., Kamei T., Flye M. W. Kupffer cell blockade increases mortality during intra-abdominal sepsis despite improving systemic immunity. Arch Surg. 1990 Jan;125(1):36–41. doi: 10.1001/archsurg.1990.01410130038005. [DOI] [PubMed] [Google Scholar]
  12. Creasey A. A., Stevens P., Kenney J., Allison A. C., Warren K., Catlett R., Hinshaw L., Taylor F. B., Jr Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli. Circ Shock. 1991 Feb;33(2):84–91. [PubMed] [Google Scholar]
  13. Espevik T., Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods. 1986 Dec 4;95(1):99–105. doi: 10.1016/0022-1759(86)90322-4. [DOI] [PubMed] [Google Scholar]
  14. Fischer E., Marano M. A., Van Zee K. J., Rock C. S., Hawes A. S., Thompson W. A., DeForge L., Kenney J. S., Remick D. G., Bloedow D. C. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest. 1992 May;89(5):1551–1557. doi: 10.1172/JCI115748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fischer E., Van Zee K. J., Marano M. A., Rock C. S., Kenney J. S., Poutsiaka D. D., Dinarello C. A., Lowry S. F., Moldawer L. L. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood. 1992 May 1;79(9):2196–2200. [PubMed] [Google Scholar]
  16. Fong Y., Lowry S. F. Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin Immunol Immunopathol. 1990 May;55(2):157–170. doi: 10.1016/0090-1229(90)90094-7. [DOI] [PubMed] [Google Scholar]
  17. Gaeta G. B., Perna P., Adinolfi L. E., Utili R., Ruggiero G. Endotoxemia in a series of 104 patients with chronic liver diseases: prevalence and significance. Digestion. 1982;23(4):239–244. doi: 10.1159/000198756. [DOI] [PubMed] [Google Scholar]
  18. Gans H., Mori K., Lindsey E., Kaster B., Richter D., Quinlan R., Dineen P. A., Tan B. H. Septicemia as a manifestation of acute liver failure. Surg Gynecol Obstet. 1971 May;132(5):783–790. [PubMed] [Google Scholar]
  19. Gazzano-Santoro H., Parent J. B., Grinna L., Horwitz A., Parsons T., Theofan G., Elsbach P., Weiss J., Conlon P. J. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun. 1992 Nov;60(11):4754–4761. doi: 10.1128/iai.60.11.4754-4761.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Granowitz E. V., Porat R., Mier J. W., Orencole S. F., Callahan M. V., Cannon J. G., Lynch E. A., Ye K., Poutsiaka D. D., Vannier E. Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans. Blood. 1993 Nov 15;82(10):2985–2990. [PubMed] [Google Scholar]
  21. Gross K., Katz S., Dunn S. P., Cikrit D., Rosenthal R., Grosfeld J. L. Bacterial clearance in the intact and regenerating liver. J Pediatr Surg. 1985 Aug;20(4):320–323. doi: 10.1016/s0022-3468(85)80211-6. [DOI] [PubMed] [Google Scholar]
  22. Hack C. E., Hart M., van Schijndel R. J., Eerenberg A. J., Nuijens J. H., Thijs L. G., Aarden L. A. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun. 1992 Jul;60(7):2835–2842. doi: 10.1128/iai.60.7.2835-2842.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hansen M. B., Nielsen S. E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods. 1989 May 12;119(2):203–210. doi: 10.1016/0022-1759(89)90397-9. [DOI] [PubMed] [Google Scholar]
  24. Helle M., Boeije L., Aarden L. A. Functional discrimination between interleukin 6 and interleukin 1. Eur J Immunol. 1988 Oct;18(10):1535–1540. doi: 10.1002/eji.1830181010. [DOI] [PubMed] [Google Scholar]
  25. Helle M., Boeije L., de Groot E., de Vos A., Aarden L. Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera. J Immunol Methods. 1991 Apr 8;138(1):47–56. doi: 10.1016/0022-1759(91)90063-l. [DOI] [PubMed] [Google Scholar]
  26. Lumsden A. B., Henderson J. M., Kutner M. H. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology. 1988 Mar-Apr;8(2):232–236. doi: 10.1002/hep.1840080207. [DOI] [PubMed] [Google Scholar]
  27. Malik A. B., Kaplan J. E., Saba T. M. Reference sample method for cardiac output and regional blood flow determinations in the rat. J Appl Physiol. 1976 Mar;40(3):472–475. doi: 10.1152/jappl.1976.40.3.472. [DOI] [PubMed] [Google Scholar]
  28. Matuschak G. M., Rinaldo J. E. Organ interactions in the adult respiratory distress syndrome during sepsis. Role of the liver in host defense. Chest. 1988 Aug;94(2):400–406. doi: 10.1378/chest.94.2.400. [DOI] [PubMed] [Google Scholar]
  29. Michalopoulos G. K. Liver regeneration: molecular mechanisms of growth control. FASEB J. 1990 Feb 1;4(2):176–187. [PubMed] [Google Scholar]
  30. Mulder M. F., van Lambalgen A. A., van Kraats A. A., Scheffer P. G., Bouman A. A., van den Bos G. C., Thijs L. G. Systemic and regional hemodynamic changes during endotoxin or platelet activating factor (PAF)-induced shock in rats. Circ Shock. 1993 Dec;41(4):221–229. [PubMed] [Google Scholar]
  31. Mészáros K., Aberle S., Dedrick R., Machovich R., Horwitz A., Birr C., Theofan G., Parent J. B. Monocyte tissue factor induction by lipopolysaccharide (LPS): dependence on LPS-binding protein and CD14, and inhibition by a recombinant fragment of bactericidal/permeability-increasing protein. Blood. 1994 May 1;83(9):2516–2525. [PubMed] [Google Scholar]
  32. Nolan J. P. Endotoxin, reticuloendothelial function, and liver injury. Hepatology. 1981 Sep-Oct;1(5):458–465. doi: 10.1002/hep.1840010516. [DOI] [PubMed] [Google Scholar]
  33. Ohlsson K., Björk P., Bergenfeldt M., Hageman R., Thompson R. C. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 1990 Dec 6;348(6301):550–552. doi: 10.1038/348550a0. [DOI] [PubMed] [Google Scholar]
  34. Ooi C. E., Weiss J., Elsbach P., Frangione B., Mannion B. A 25-kDa NH2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein. J Biol Chem. 1987 Nov 5;262(31):14891–14894. [PubMed] [Google Scholar]
  35. Rolando N., Harvey F., Brahm J., Philpott-Howard J., Alexander G., Gimson A., Casewell M., Fagan E., Williams R. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology. 1990 Jan;11(1):49–53. doi: 10.1002/hep.1840110110. [DOI] [PubMed] [Google Scholar]
  36. Simons R. K., Maier R. V., Lennard E. S. Neutrophil function in a rat model of endotoxin-induced lung injury. Arch Surg. 1987 Feb;122(2):197–203. doi: 10.1001/archsurg.1987.01400140079010. [DOI] [PubMed] [Google Scholar]
  37. Stone M. D., Benotti P. N. Liver resection. Preoperative and postoperative care. Surg Clin North Am. 1989 Apr;69(2):383–392. doi: 10.1016/s0039-6109(16)44793-6. [DOI] [PubMed] [Google Scholar]
  38. Tran D. D., Groeneveld A. B., van der Meulen J., Nauta J. J., Strack van Schijndel R. J., Thijs L. G. Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med. 1990 May;18(5):474–479. doi: 10.1097/00003246-199005000-00002. [DOI] [PubMed] [Google Scholar]
  39. Van Leeuwen P. A., Bading J. R., Vydelingum N. A., Younes R. N., de Rooij P., Brennan M. F. Organ blood flow in Fischer-344 rats bearing MCA-induced sarcoma. J Appl Physiol (1985) 1991 Nov;71(5):1674–1678. doi: 10.1152/jappl.1991.71.5.1674. [DOI] [PubMed] [Google Scholar]
  40. Vo N. M., Chi D. S. Effect of hepatectomy on the reticuloendothelial system of septic rats. J Trauma. 1988 Jun;28(6):852–854. doi: 10.1097/00005373-198806000-00025. [DOI] [PubMed] [Google Scholar]
  41. Wakabayashi G., Gelfand J. A., Burke J. F., Thompson R. C., Dinarello C. A. A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits. FASEB J. 1991 Mar 1;5(3):338–343. doi: 10.1096/fasebj.5.3.1825816. [DOI] [PubMed] [Google Scholar]
  42. Weiss J., Elsbach P., Olsson I., Odeberg H. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem. 1978 Apr 25;253(8):2664–2672. [PubMed] [Google Scholar]
  43. Wilkinson S. P., Arroyo V., Gazzard B. G., Moodie H., Williams R. Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure. Lancet. 1974 Mar 30;1(7857):521–524. doi: 10.1016/s0140-6736(74)92711-1. [DOI] [PubMed] [Google Scholar]
  44. Wortel C. H., van Deventer S. J., Aarden L. A., Lygidakis N. J., Büller H. R., Hoek F. J., Horikx J., ten Cate J. W. Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery. 1993 Sep;114(3):564–570. [PubMed] [Google Scholar]
  45. de Waal Malefyt R., Abrams J., Bennett B., Figdor C. G., de Vries J. E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991 Nov 1;174(5):1209–1220. doi: 10.1084/jem.174.5.1209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. van Deventer S. J., Büller H. R., ten Cate J. W., Aarden L. A., Hack C. E., Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood. 1990 Dec 15;76(12):2520–2526. [PubMed] [Google Scholar]
  47. van Gool J., van Vugt H., Helle M., Aarden L. A. The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. Clin Immunol Immunopathol. 1990 Nov;57(2):200–210. doi: 10.1016/0090-1229(90)90034-n. [DOI] [PubMed] [Google Scholar]
  48. van Lambalgen A. A., van Kraats A. A., van den Bos G. C., Stel H. V., Straub J., Donker A. J., Thijs L. G. Renal function and metabolism during endotoxemia in rats: role of hypoperfusion. Circ Shock. 1991 Nov;35(3):164–173. [PubMed] [Google Scholar]
  49. van Lambalgen A. A., van den Bos G. C., Thijs L. G. Changes in regional plasma extravasation in rats following endotoxin infusion. Microvasc Res. 1987 Jul;34(1):116–132. doi: 10.1016/0026-2862(87)90084-7. [DOI] [PubMed] [Google Scholar]
  50. van Leeuwen P. A., Hong R. W., Rounds J. D., Rodrick M. L., Wilmore D. Hepatic failure and coma after liver resection is reversed by manipulation of gut contents: the role of endotoxin. Surgery. 1991 Aug;110(2):169–175. doi: 10.1016/0261-5614(91)90171-8. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES